ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Top Stocks Set to Outperform
Over the Next 1 to 3 Months.
Click for your free picks >>

Quote:

Search for Ticker

Free Membership

Search:

CHTT: Chattem Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

CHATTEM INC (NASD)
CHTT	67.25	0.81	(1.22%)	Vol. 134,682	16:00 ET

Chattem, Inc. is a leading marketer and manufacturer of a variety of branded consumer products, including over-the-counter health care and toiletries and skin care products. The company's high quality brandedproducts target niche market segments and are among the market leaders in their respective categories. Through creative and cost effective marketing techniques, these brands on a national level across all major distributionchannels, including food, drug and mass merchandisers.

General Information

CHATTEM INC

1715 West 38th Street Chattanooga, TN 37409 Phone: 423 821-4571 Fax: 423 821-0395 Web: www.chattem.com Email: webmaster@chattem.com

Industry	MED-DRUGS
Sector:	Medical

Fiscal Year End	November
Last Reported Quarter	08/31/09
Next EPS Date	02/04/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	66.44
52 Week High	72.93
52 Week Low	50.10
Beta	0.25
20 Day Moving Average	191,393.16
Target Price Consensus	70.63

% Price Change
4 Week	2.06
12 Week	7.73
YTD	-7.12

% Price Change Relative to S&P 500
4 Week	0.96
12 Week	1.57
YTD	-23.13

Share Information
Shares Outstanding (millions)	19.04
Market Capitalization (millions)	1,265.22
Short Ratio	12.95
Last Split Date	12/02/2002

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	1.06
Current Year EPS Consensus Estimate	4.57
Estimated Long-Term EPS Growth Rate	11.40
Next EPS Report Date	02/04/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	1.89
30 Days Ago	1.89
60 Days Ago	1.89
90 Days Ago	2.00

Fundamental Ratios

P/E
Current FY Estimate:	14.55
Trailing 12 Months:	15.24
PEG Ratio	1.28

EPS Growth
vs. Previous Year	14.81%
vs. Previous Quarter	-1.59%

Sales Growth
vs. Previous Year	2.90%
vs. Previous Quarter:	-5.47%

Price Ratios
Price/Book	4.23
Price/Cash Flow	14.73
Price / Sales	2.76

ROE
08/31/09	29.35
05/31/09	29.58
02/28/09	30.35

ROA
08/31/09	10.56
05/31/09	10.19
02/28/09	9.80

Current Ratio
08/31/09	-
05/31/09	3.27
02/28/09	2.70

Quick Ratio
08/31/09	-
05/31/09	2.21
02/28/09	1.86

Operating Margin
08/31/09	18.43
05/31/09	17.85
02/28/09	17.28

Net Margin
08/31/09	-
05/31/09	24.90
02/28/09	23.85

Pre-Tax Margin
08/31/09	-
05/31/09	24.90
02/28/09	23.85

Book Value
08/31/09	-
05/31/09	15.70
02/28/09	15.56

Inventory Turnover
08/31/09	-
05/31/09	3.17
02/28/09	3.13

Debt-to-Equity
08/31/09	-
05/31/09	1.33
02/28/09	1.35

Debt to Capital
08/31/09	-
05/31/09	57.14
02/28/09	57.36


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research